239 related articles for article (PubMed ID: 17561929)
1. Safety of levocetirizine treatment in young atopic children: An 18-month study.
Simons FE;
Pediatr Allergy Immunol; 2007 Sep; 18(6):535-42. PubMed ID: 17561929
[TBL] [Abstract][Full Text] [Related]
2. H1-antihistamine treatment in young atopic children: effect on urticaria.
Simons FE;
Ann Allergy Asthma Immunol; 2007 Sep; 99(3):261-6. PubMed ID: 17910330
[TBL] [Abstract][Full Text] [Related]
3. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial.
de Blic J; Wahn U; Billard E; Alt R; Pujazon MC
Pediatr Allergy Immunol; 2005 May; 16(3):267-75. PubMed ID: 15853959
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of levocetirizine in very young children: the pediatricians' perspective.
Simons FE;
Pediatr Allergy Immunol; 2005 Mar; 16(2):97-103. PubMed ID: 15787865
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial.
Potter PC;
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):175-80. PubMed ID: 16136768
[TBL] [Abstract][Full Text] [Related]
6. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up.
Warner JO;
J Allergy Clin Immunol; 2001 Dec; 108(6):929-37. PubMed ID: 11742270
[TBL] [Abstract][Full Text] [Related]
7. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
[TBL] [Abstract][Full Text] [Related]
8. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
Kapp A; Pichler WJ
Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
[TBL] [Abstract][Full Text] [Related]
9. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
10. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.
Bachert C; Bousquet J; Canonica GW; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB; Van Hammée G;
J Allergy Clin Immunol; 2004 Oct; 114(4):838-44. PubMed ID: 15480324
[TBL] [Abstract][Full Text] [Related]
11. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child.
Pediatr Allergy Immunol; 1998 Aug; 9(3):116-24. PubMed ID: 9814724
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
Zuberbier T; Oanta A; Bogacka E; Medina I; Wesel F; Uhl P; Antépara I; Jáuregui I; Valiente R;
Allergy; 2010 Apr; 65(4):516-28. PubMed ID: 19860762
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study.
Grimfeld A; Holgate ST; Canonica GW; Bonini S; Borres MP; Adam D; Canseco Gonzalez C; Lobaton P; Patel P; Szczeklik A; Danzig MR; Roman I; Bismut H; Czarlewski W
Clin Exp Allergy; 2004 Nov; 34(11):1665-72. PubMed ID: 15544588
[TBL] [Abstract][Full Text] [Related]
14. Retrospective population pharmacokinetics of levocetirizine in atopic children receiving cetirizine: the ETAC study.
Hussein Z; Pitsiu M; Majid O; Aarons L; de Longueville M; Stockis A;
Br J Clin Pharmacol; 2005 Jan; 59(1):28-37. PubMed ID: 15606437
[TBL] [Abstract][Full Text] [Related]
15. Evidence for clinical safety, efficacy, and parent and physician perceptions of levocetirizine for the treatment of children with allergic disease.
Pampura AN; Papadopoulos NG; Spičák V; Kurzawa R
Int Arch Allergy Immunol; 2011; 155(4):367-78. PubMed ID: 21346367
[TBL] [Abstract][Full Text] [Related]
16. Costs associated with persistent allergic rhinitis are reduced by levocetirizine.
Bousquet J; Demarteau N; Mullol J; van den Akker-van Marle ME; Van Ganse E; Bachert C;
Allergy; 2005 Jun; 60(6):788-94. PubMed ID: 15876309
[TBL] [Abstract][Full Text] [Related]
17. Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study.
Ciprandi G; Cirillo IG; Vizzaccaro A; Tosca MA
Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):25-9. PubMed ID: 15745374
[TBL] [Abstract][Full Text] [Related]
18. A review of the role of levocetirizine as an effective therapy for allergic disease.
Walsh GM
Expert Opin Pharmacother; 2008 Apr; 9(5):859-67. PubMed ID: 18345961
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of cetirizine and levocetirizine in chronic idiopathic urticaria.
Garg G; Thami GP
J Dermatolog Treat; 2007; 18(1):23-4. PubMed ID: 17365263
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the sedating effects of levocetirizine and cetirizine: a randomized, double-blind, placebo-controlled trial.
Tzanetos DB; Fahrenholz JM; Scott T; Buchholz K
Ann Allergy Asthma Immunol; 2011 Dec; 107(6):517-22. PubMed ID: 22123381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]